The potential of ARL4C and its-mediated genes in atherosclerosis and agent development
Foam cells are the risk factors for atherosclerosis. Recently, ARL4C, a member of the ADP-ribosylation factor family of GTP-binding proteins, was found to promote cholesterol efflux to decrease foam cell formation, suggesting that ARL4C may be a new promising target for the treatment of atherosclero...
Saved in:
| Main Authors: | Dan Liu, Jie Wang, Shuangshuang Zhang, Hongfei Jiang, Yudong Wu, Chao Wang, Wujun Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1513340/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resveratrol promotes cholesterol efflux from dendritic cells and controls costimulation and T-cell activation in high-fat and lipopolysaccharide-driven atherosclerotic mice
by: Linhui Zhang, et al.
Published: (2024-12-01) -
Small GTPase ARL4C Associated with Various Cancers Affects Microtubule Nucleation
by: Evgeniia Ulas, et al.
Published: (2024-12-01) -
ABCA6 Regulates Chondrogenesis and Inhibits Joint Degeneration via Orchestrated Cholesterol Efflux and Cellular Senescence
by: Yi Wang, et al.
Published: (2025-03-01) -
CD73: agent development potential and its application in diabetes and atherosclerosis
by: Dan Liu, et al.
Published: (2024-12-01) -
Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis
by: Julie Gall, et al.
Published: (2016-12-01)